Back to top

Altimmune’s RECLAIM Study Adds an Addiction Angle to Its Obesity Drug

Altimmune ($ALT) announced an update on their ongoing clinical study. Altimmune’s RECLAIM study looks at whether its drug pemvidutide can help trea...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Altimmune, Inc. (ALT)